# Marrow Therapeutics

> Preclinical in-vivo genetic medicines targeting bone marrow in sickle-cell disease and beta thalassemia.

## Why it is interesting

The company disclosed two distinct financing tranches totaling $173M and a tissue-targeted antibody-cargo approach that still faces demanding clinical and anemia-safety validation.

## Profile

- **Latest funding:** Series A (historical closing date not disclosed; revealed November 17, 2026) — $53M (Date not disclosed)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $173M
- **Stage:** series-b
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-18T00:00:00.000Z
- **Latest funding investors:** Scion Life Sciences, venBio

## Key facts

- $173M is $53M Series A plus $120M Series B, not a separate financing.
- The original close dates remain undisclosed; November 17 is disclosure date.
- Lead candidate is preclinical IND-enabling, with TfR1 off-target anemia risk to address.

## Funding history

- Series A (historical closing date not disclosed; revealed November 17, 2026) · $53M
  Source: https://www.marrowtx.com/news/marrow-therapeutics-launches-with-173-million-to-develop-genetic-medicines-for-bone-marrow-disorders/
- Series B (historical closing date not disclosed; revealed November 17, 2026) · $120M
  Source: https://www.marrowtx.com/news/marrow-therapeutics-launches-with-173-million-to-develop-genetic-medicines-for-bone-marrow-disorders/

## Investors in our directory

- https://venturecapitaltracker.com/fund/scion-life-sciences
- https://venturecapitaltracker.com/fund/venbio
- https://venturecapitaltracker.com/fund/orbimed

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 18, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/marrow-therapeutics-bone-marrow-genetic-medicine
